| Medical and Health Sciences | Lifetime | 307 | US 169 | 99.99 |
| Ophthalmology | Lifetime | 6 | US 4 | 99.97 |
| Oncology | Lifetime | 272 | US 155 | 99.56 |
| Radiology, Nuclear Medicine and Imaging | Lifetime | 393 | US 223 | 99.06 |
| Clinical Neurology | Lifetime | 397 | US 182 | 98.34 |
| Dermatology | Lifetime | 330 | US 134 | 97.84 |
| Genetics | Lifetime | 920 | US 476 | 97.73 |
| Rheumatology | Lifetime | 824 | US 378 | 95.48 |
| Medical Genetics | Lifetime | 692 | US 342 | 92.36 |
| Ophthalmology | 2021-2025 | 163 | US 66 | 93.68 |
| Cancer and Skin Lesions | Lifetime | 4 | US 3 | 99.82 |
| Nonmelanoma Skin Cancer Studies | Lifetime | 4 | US 2 | 99.82 |
| Ocular Infections and Treatments | Lifetime | 2 | US 2 | 99.88 |
| Ocular Oncology and Treatments | Lifetime | 2 | US 2 | 99.90 |
| Drug-Induced Ocular Toxicity | Lifetime | 1 | US 1 | 99.39 |
| Glaucoma and retinal disorders | Lifetime | 22 | US 13 | 99.85 |
| Ocular Disorders and Treatments | Lifetime | 2 | US 2 | 99.82 |
| Retinal Development and Disorders | Lifetime | 14 | US 12 | 99.75 |
| Cutaneous Melanoma Detection and Management | Lifetime | 15 | US 6 | 99.83 |
| Ear and Head Tumors | Lifetime | 15 | US 11 | 99.67 |
| Ocular Diseases and Behçet’s Syndrome | Lifetime | 22 | US 15 | 99.65 |
| Soft tissue tumor case studies | Lifetime | 14 | US 9 | 99.68 |
| Brain Metastases and Treatment | Lifetime | 30 | US 22 | 99.67 |
| Vascular Tumors and Angiosarcomas | Lifetime | 16 | US 11 | 99.66 |
| melanin and skin pigmentation | Lifetime | 22 | US 11 | 99.39 |
| Retinal Diseases and Treatments | Lifetime | 65 | US 39 | 99.65 |
| Retinal and Macular Surgery | Lifetime | 21 | US 15 | 99.62 |
| Head and Neck Surgical Oncology | Lifetime | 72 | US 51 | 99.53 |
| Glioma Diagnosis and Treatment | Lifetime | 164 | US 102 | 99.40 |
| Corneal Surgery and Treatments | Lifetime | 60 | US 26 | 99.27 |
| Retinal and Optic Conditions | Lifetime | 74 | US 39 | 99.42 |
| Genetic and rare skin diseases. | Lifetime | 22 | US 13 | 99.09 |
| Histiocytic Disorders and Treatments | Lifetime | 22 | US 13 | 99.15 |
| Vascular Malformations and Hemangiomas | Lifetime | 43 | US 28 | 98.67 |
| CNS Lymphoma Diagnosis and Treatment | Lifetime | 46 | US 23 | 99.35 |
| Cancer-related Molecular Pathways | Lifetime | 339 | US 202 | 98.76 |
| Neurofibromatosis and Schwannoma Cases | Lifetime | 120 | US 79 | 98.39 |
| Teratomas and Epidermoid Cysts | Lifetime | 29 | US 24 | 98.01 |
| Tumors and Oncological Cases | Lifetime | 203 | US 127 | 97.98 |
| Vascular Malformations Diagnosis and Treatment | Lifetime | 239 | US 155 | 98.22 |
| Bone Tumor Diagnosis and Treatments | Lifetime | 288 | US 148 | 97.98 |
| Meningioma and schwannoma management | Lifetime | 343 | US 187 | 98.12 |
| Salivary Gland Tumors Diagnosis and Treatment | Lifetime | 335 | US 166 | 97.86 |
| Tuberous Sclerosis Complex Research | Lifetime | 64 | US 38 | 96.65 |
| Sarcoma Diagnosis and Treatment | Lifetime | 785 | US 380 | 97.38 |
| Cerebral Venous Sinus Thrombosis | Lifetime | 280 | US 146 | 96.66 |
| Hedgehog Signaling Pathway Studies | Lifetime | 240 | US 130 | 96.38 |
| Ocular and Laser Science Research | Lifetime | 179 | US 84 | 96.87 |
| Melanoma and MAPK Pathways | Lifetime | 287 | US 153 | 96.98 |
| Nasolacrimal Duct Obstruction Treatments | Lifetime | 38 | US 18 | 95.99 |
| Oral and Maxillofacial Pathology | Lifetime | 982 | US 324 | 95.82 |
| Intraocular Surgery and Lenses | Lifetime | 957 | US 385 | 96.02 |
| Dermatological and Skeletal Disorders | Lifetime | 386 | US 133 | 93.27 |
| Facial Trauma and Fracture Management | Lifetime | 625 | US 232 | 93.12 |
| Genetic and Kidney Cyst Diseases | Lifetime | 793 | US 335 | 91.92 |
| Soft tissue tumors and treatment | Lifetime | 215 | US 102 | 88.75 |
| IgG4-Related and Inflammatory Diseases | Lifetime | 996 | US 236 | 79.02 |
| Infectious Disease Case Reports and Treatments | Lifetime | 467 | US 231 | 74.84 |
| Ocular Oncology and Treatments | 2021-2025 | 36 | US 14 | 96.33 |
| Brain Metastases and Treatment | 2021-2025 | 585 | US 265 | 87.63 |
| Cutaneous Melanoma Detection and Management | 2021-2025 | 902 | US 245 | 81.23 |
| Vascular Tumors and Angiosarcomas | 2021-2025 | 346 | US 129 | 73.49 |
